BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26796853)

  • 21. The clinicopathological significance and potential drug target of E-cadherin in NSCLC.
    Zhong K; Chen W; Xiao N; Zhao J
    Tumour Biol; 2015 Aug; 36(8):6139-48. PubMed ID: 25758052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinicopathological significance of WIF1 hypermethylation in NSCLC, a meta-analysis and literature review.
    Guo H; Zhou S; Tan L; Wu X; Wu Z; Ran R
    Oncotarget; 2017 Jan; 8(2):2550-2557. PubMed ID: 27911280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced Fhit protein expression and loss of heterozygosity at FHIT gene in tumours from smoking and asbestos-exposed lung cancer patients.
    Pylkkanen L; Wolff H; Stjernvall T; Tuominen P; Sioris T; Karjalainen A; Anttila S; Husgafvel-Pursiainen K
    Int J Oncol; 2002 Feb; 20(2):285-90. PubMed ID: 11788890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synergistic tumor suppression by coexpression of FHIT and p53 coincides with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-small cell lung cancer cells.
    Nishizaki M; Sasaki J; Fang B; Atkinson EN; Minna JD; Roth JA; Ji L
    Cancer Res; 2004 Aug; 64(16):5745-52. PubMed ID: 15313915
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinicopathological significance of Fhit protein expression in stage I non-small cell lung carcinoma.
    Tomizawa Y; Nakajima T; Kohno T; Saito R; Yamaguchi N; Yokota J
    Cancer Res; 1998 Dec; 58(23):5478-83. PubMed ID: 9850082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FHIT
    Da Silva J; Jouida A; Ancel J; Dalstein V; Routhier J; Delepine G; Cutrona J; Jonquet A; Dewolf M; Birembaut P; Deslée G; Polette M; Nawrocki-Raby B
    J Pathol; 2020 Jun; 251(2):187-199. PubMed ID: 32237123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A systematic review and meta-analysis: Association between MGMT hypermethylation and the clinicopathological characteristics of non-small-cell lung carcinoma.
    Chen L; Wang Y; Liu F; Xu L; Peng F; Zhao N; Fu B; Zhu Z; Shi Y; Liu J; Wu R; Wang C; Yao S; Li Y
    Sci Rep; 2018 Jan; 8(1):1439. PubMed ID: 29362385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological significance and a potential drugtarget of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review.
    Song X; Shi K; Zhou SJ; Yu DP; Liu Z; Han Y
    Drug Des Devel Ther; 2016; 10():1345-54. PubMed ID: 27103788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer.
    Woenckhaus M; Merk J; Stoehr R; Schaeper F; Gaumann A; Wiebe K; Hartmann A; Hofstaedter F; Dietmaier W
    Hum Pathol; 2008 Jan; 39(1):126-36. PubMed ID: 17949785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Promoter methylation status of the FHIT gene and Fhit expression: association with HER2/neu status in breast cancer patients.
    Jeong YJ; Jeong HY; Lee SM; Bong JG; Park SH; Oh HK
    Oncol Rep; 2013 Nov; 30(5):2270-8. PubMed ID: 23969757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological significance of DAPK gene promoter hypermethylation in non-small cell lung cancer: A meta-analysis.
    Chen Z; Fan Y; Liu X; Shang X; Qi K; Zhang S
    Int J Biol Markers; 2022 Mar; 37(1):47-57. PubMed ID: 34935548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A meta-analysis for CXCR4 as a prognostic marker and potential drug target in non-small cell lung cancer.
    Zhang C; Li J; Han Y; Jiang J
    Drug Des Devel Ther; 2015; 9():3267-78. PubMed ID: 26150700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. c-Myc suppresses microRNA-29b to promote tumor aggressiveness and poor outcomes in non-small cell lung cancer by targeting FHIT.
    Wu DW; Hsu NY; Wang YC; Lee MC; Cheng YW; Chen CY; Lee H
    Oncogene; 2015 Apr; 34(16):2072-82. PubMed ID: 24909176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Yendamuri S; Matsuyama A; Alder H; Mori M; Croce CM
    Cancer Res; 2003 Jul; 63(13):3724-8. PubMed ID: 12839965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promoter hypermethylation of RASSF1A and RUNX3 genes as an independent prognostic prediction marker in surgically resected non-small cell lung cancers.
    Yanagawa N; Tamura G; Oizumi H; Kanauchi N; Endoh M; Sadahiro M; Motoyama T
    Lung Cancer; 2007 Oct; 58(1):131-8. PubMed ID: 17606310
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The relationship between FHIT gene promoter methylation and lung cancer risk: a meta-analysis].
    Sun Y
    Zhongguo Fei Ai Za Zhi; 2014 Mar; 17(3):233-7. PubMed ID: 24667261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analyses of gene methylation and smoking behavior in non-small cell lung cancer patients.
    Huang T; Chen X; Hong Q; Deng Z; Ma H; Xin Y; Fang Y; Ye H; Wang R; Zhang C; Ye M; Duan S
    Sci Rep; 2015 Mar; 5():8897. PubMed ID: 25754026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
    Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
    Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative assessment of lung cancer associated with genes methylation in the peripheral blood.
    Tan S; Sun C; Wei X; Li Y; Wu Y; Yan Z; Feng F; Wang J; Wu Y
    Exp Lung Res; 2013; 39(4-5):182-90. PubMed ID: 23614702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fragile genes as biomarkers: epigenetic control of WWOX and FHIT in lung, breast and bladder cancer.
    Iliopoulos D; Guler G; Han SY; Johnston D; Druck T; McCorkell KA; Palazzo J; McCue PA; Baffa R; Huebner K
    Oncogene; 2005 Feb; 24(9):1625-33. PubMed ID: 15674328
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.